NCT02189057View on ClinicalTrials.gov

A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management Of Depression

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

October 19, 2018

Study Completion Date

October 19, 2018

Conditions
DepressionMood DisorderBipolar
Interventions
OTHER

AssureRx GeneSight genotyping results

OTHER

Treatment as usual

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT02189057 - A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management Of Depression | Biotech Hunter | Biotech Hunter